MW3882A1 - Pharmaceutical formulations comprising human insulin human c-peptide - Google Patents

Pharmaceutical formulations comprising human insulin human c-peptide

Info

Publication number
MW3882A1
MW3882A1 MW38/82A MW3882A MW3882A1 MW 3882 A1 MW3882 A1 MW 3882A1 MW 38/82 A MW38/82 A MW 38/82A MW 3882 A MW3882 A MW 3882A MW 3882 A1 MW3882 A1 MW 3882A1
Authority
MW
MALAWI
Prior art keywords
human
peptide
pharmaceutical formulations
human insulin
insulin human
Prior art date
Application number
MW38/82A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MW3882A1 publication Critical patent/MW3882A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MW38/82A 1981-08-27 1982-08-24 Pharmaceutical formulations comprising human insulin human c-peptide MW3882A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
MW3882A1 true MW3882A1 (en) 1984-07-11

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
MW38/82A MW3882A1 (en) 1981-08-27 1982-08-24 Pharmaceutical formulations comprising human insulin human c-peptide

Country Status (20)

Country Link
JP (1) JPS5846024A (it)
AU (1) AU551879B2 (it)
BE (1) BE894185A (it)
CA (1) CA1176158A (it)
CH (1) CH650679A5 (it)
DE (1) DE3232034A1 (it)
DZ (1) DZ452A1 (it)
FR (1) FR2513126B1 (it)
GB (1) GB2104382B (it)
IE (1) IE54119B1 (it)
IL (1) IL66611A0 (it)
IT (1) IT1153182B (it)
LU (1) LU84359A1 (it)
MW (1) MW3882A1 (it)
NL (1) NL192192C (it)
NZ (1) NZ201682A (it)
PH (1) PH19361A (it)
SE (1) SE460334B (it)
ZA (1) ZA826159B (it)
ZW (1) ZW17482A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
WO1988002633A1 (en) * 1986-10-20 1988-04-21 Novo Industri A/S Protamine zinc insulin preparations
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
CA1339416C (en) * 1987-02-25 1997-09-02 Liselotte Langkjaer Insulin derivatives
EP0303308B1 (en) * 1987-08-14 1991-05-29 Akzo N.V. Preparation for preventing or combating complications in diabetes
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
WO2006053906A1 (en) * 2004-11-22 2006-05-26 Novo Nordisk A/S Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
KR20130115086A (ko) * 2010-05-17 2013-10-21 세빅스 인코포레이티드 페길화된 c-펩티드
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
IT1153182B (it) 1987-01-14
BE894185A (fr) 1983-02-24
IE54119B1 (en) 1989-06-21
DZ452A1 (fr) 2004-09-13
FR2513126A1 (fr) 1983-03-25
IT8223017A0 (it) 1982-08-27
ZA826159B (en) 1984-04-25
NL192192B (nl) 1996-11-01
ZW17482A1 (en) 1982-11-17
PH19361A (en) 1986-04-02
SE460334B (sv) 1989-10-02
NL8203315A (nl) 1983-03-16
GB2104382A (en) 1983-03-09
DE3232034C2 (it) 1991-04-11
NL192192C (nl) 1997-03-04
AU8759482A (en) 1983-03-03
NZ201682A (en) 1985-08-16
DE3232034A1 (de) 1983-03-10
SE8204873L (sv) 1983-02-28
LU84359A1 (fr) 1983-02-28
FR2513126B1 (fr) 1986-04-18
SE8204873D0 (sv) 1982-08-25
AU551879B2 (en) 1986-05-15
IL66611A0 (en) 1982-12-31
JPS5846024A (ja) 1983-03-17
GB2104382B (en) 1984-12-19
CA1176158A (en) 1984-10-16
IE822064L (en) 1983-02-27
CH650679A5 (de) 1985-08-15

Similar Documents

Publication Publication Date Title
ZA828797B (en) Pharmaceutical formulation
DE3264782D1 (en) Medicinal formulation
GB2105191B (en) Pharmaceutical formulations comprising human insulin and human proinsulin
MW3882A1 (en) Pharmaceutical formulations comprising human insulin human c-peptide
MY8600312A (en) Pharmaceutical formulations
GB2104380B (en) Human proinsulin pharmaceutical formulations
GB2104381B (en) Pharmaceutical formulations comprising human insulin, human c-peptide, and human proinsulin
IE812104L (en) Novel insulin formulations based on human insulin
IE822065L (en) Insulin and proinsulin formulations
JO1238B1 (en) Pharmacy formulations include human insulin, human peptide-C and the human insulin component